Quercetin Ameliorates Cognitive Impairment in App/Ps1 Mice Via Gut
Microbiota Modulation and Tryptophan Metabolism Restoration
Ying Feng1☨,
Yan hua Shi2☨,
Tao Wang3, Jin yang Han1, Dan dan Li1,
Xiao tong Zhang1, Qian Xu1, Feng Liu4,
Jingjing Wei4 and Xinjun Yu1*
1Affiliated
Hospital of Shandong Second Medical University, Weifang, China;
2College
of Life Science and Technology, Shandong Second Medical University,
Weifang, China;
3School of Clinical Medicine, Affiliated Hospital of
Shandong Second Medical University, Weifang, China: 4College
of Veterinary Medicine, Northwest A&F University, 712100 Yangling,
China.
☨These
authors contributed equally to this work.
*Corresponding author:
fyyuxj@sdsmu.edu.cn
Abstract
Emerging evidence positions the bidirectional microbiome-brain communication
network as a tractable intervention point in neurodegeneration. Yet whether
dietary flavonoids can leverage this axis to counteract cognitive decline
remains incompletely characterized. Three cohorts of male APP/PS1 mice underwent
daily oral administration of quercetin (100mg/kg body weight) or saline vehicle
over a 6-month intervention period. Spatial learning and memory were evaluated
through Morris Water Maze paradigms. Multi-omics profiling encompassed fecal
microbiome characterization (16S rRNA gene amplicon sequencing), serum
metabolomic analysis (liquid chromatography-tandem mass spectrometry), and
hippocampal transcriptome mapping (RNA sequencing). Relative to vehicle-treated
APP/PS1 controls, quercetin intervention elicited marked improvements across
multiple spatial memory indices. Specifically, treated animals demonstrated
enhanced target quadrant exploration (swimming distance: 11±2m
versus 9±2.5m
in controls; P<0.001) and prolonged occupancy within the goal zone (12.3±2.2s
compared to 7.5±2.2s;
P<0.001). Platform crossing frequency nearly doubled following quercetin
administration (4.4±0.6
versus 2.1±0.6
crossings; P<0.01), while acquisition-phase escape latency on day 5
decreased by 23% (30s versus 39s in untreated mice). These behavioral
improvements coincided with substantial gut microbiome restructuring,
characterized by a 3.6-fold reduction in pathogenic Escherichia-Shigella
abundance (log2fold-change = -1.83; P<0.001). Concurrently,
circulating tryptophan concentrations rose by 26% (from 380±86
to 480±88ng/mL;
P<0.01), while its microbial-derived metabolite indole-3-propionic acid
exhibited an 89% increase (579±99ng/mL
in controls versus 1098±83ng/mL
post-treatment; P<0.001). Transcriptomic interrogation of brain tissue
identified significant enrichment of aryl hydrocarbon receptor signaling. Our
findings demonstrate that quercetin counteracts Alzheimer's-associated cognitive
impairment via coordinated restoration of intestinal microbial ecology and
tryptophan catabolic pathways, with aryl hydrocarbon receptor activation
potentially serving as a downstream neuroprotective effector mechanism.
To Cite This Article:
Feng Y, Shi YH, Wang T, Han JY, Li D, Zhang XT, Xu Q, Liu F, Wei J and Yu X,
2025. Quercetin ameliorates cognitive impairment in app/ps1 mice via gut
microbiota modulation and tryptophan metabolism restoration.
Pak Vet J, 45(4): 1698-1709.
http://dx.doi.org/10.29261/pakvetj/2025.xxx